Follow Newser on Twitter   Friend Newser on Facebook
Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Bristol-Myers Makes Bid for Icahn's ImClone

Offers 29% premium for biotech partner; shares soar

By Kevin Spak,  Newser Staff

Posted Jul 31, 2008 1:21 PM CDT

(Newser) – Already a 17% shareholder, Bristol-Myers Squibb laid down a $4.5 billion offer to buy the  rest of ImClone shares, the Wall Street Journal reports. The $60-a-share offer, sent to ImClone chairman Carl Icahn today, is a 29% premium on yesterday's closing price and makes...   Read full story »

COMMENTS
You need to Log in to Newser to comment. Don't have an account yet? Sign up now!
There are no comments
A snapshot of the day's best news stories.
 

More Newser Stories

Pfizer Snaps Up Wyeth for $68B

Pfizer in Talks to Buy Wyeth

Icahn: Microsoft Will Only Negotiate With Me

Icahn: Yahoo Poison Pill 'Reprehensible'

Yahoo Says Icahn Doesn't Understand Full Picture


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   BuzzFeed   |   Cracked   |   Timelines   |   Geek Sugar   |   Business Insider   |   HuffPost Entertainment